Super-omics and PCAS reveal rheumatoid arthritis as a tumor-like disease
Guardat en:
| Publicat a: | bioRxiv (Jan 22, 2025) |
|---|---|
| Autor principal: | |
| Altres autors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Publicat: |
Cold Spring Harbor Laboratory Press
|
| Matèries: | |
| Accés en línia: | Citation/Abstract Full text outside of ProQuest |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
MARC
| LEADER | 00000nab a2200000uu 4500 | ||
|---|---|---|---|
| 001 | 3158241600 | ||
| 003 | UK-CbPIL | ||
| 022 | |a 2692-8205 | ||
| 024 | 7 | |a 10.1101/2025.01.17.633562 |2 doi | |
| 035 | |a 3158241600 | ||
| 045 | 0 | |b d20250122 | |
| 100 | 1 | |a Xiao, Lanlan | |
| 245 | 1 | |a Super-omics and PCAS reveal rheumatoid arthritis as a tumor-like disease | |
| 260 | |b Cold Spring Harbor Laboratory Press |c Jan 22, 2025 | ||
| 513 | |a Working Paper | ||
| 520 | 3 | |a Rheumatoid arthritis (RA) is a debilitating systemic autoimmune disorder that significantly impairs quality of life. To elucidate the molecular alterations in RA progression, we performed comprehensive super-omics analyses on synovial tissues from patients with joint trauma, arthritis, and RA. These analyses included transcriptomics, proteomics, metabolomics, microbiomics, and fourteen PTMs (phosphorylation, acetylation, lactylation, O-GlcNAc glycosylation, arginine monomethylation, lysine monomethylation, lysine dimethylation, lysine trimethylation, succinylation, malonylation, glutarylation, tyrosine nitration, N-glycosylation, and O-glycosylation). Additionally, we developed a protein-centered association study (PCAS) method to integrate these complex datasets. Using this approach, we identified key proteins, such as STK17B, and its interactors, which may be crucial in RA pathogenesis. Tumor-like features, including aberrant angiogenesis and epithelial-mesenchymal transition, were observed in RA, alongside the potential involvement of oncogenes and tumor suppressor genes. Finally, we constructed a molecular interaction blueprint of RA, providing a comprehensive framework for advancing RA pathogenesis, diagnosis, and therapy.Competing Interest StatementThe authors have declared no competing interest. | |
| 653 | |a Rheumatoid arthritis | ||
| 653 | |a Tumor suppressor genes | ||
| 653 | |a Pathogenesis | ||
| 653 | |a Glycosylation | ||
| 653 | |a Phosphorylation | ||
| 653 | |a Metabolomics | ||
| 653 | |a Angiogenesis | ||
| 653 | |a Acetylation | ||
| 653 | |a Nitration | ||
| 653 | |a Quality of life | ||
| 653 | |a Tumors | ||
| 653 | |a Transcriptomics | ||
| 653 | |a Lysine | ||
| 653 | |a Methylation | ||
| 653 | |a Proteomics | ||
| 700 | 1 | |a Aishan, Nadire | |
| 700 | 1 | |a Ju, Siwei | |
| 700 | 1 | |a Zhao, Fengchao | |
| 700 | 1 | |a Ouyang, Xiaoxi | |
| 700 | 1 | |a Chen, Dazhi | |
| 700 | 1 | |a Chen, Weiqian | |
| 700 | 1 | |a Xie, Jie | |
| 700 | 1 | |a Zhu, Danhua | |
| 700 | 1 | |a Zhang, Junchi | |
| 700 | 1 | |a Sun, Lingyun | |
| 700 | 1 | |a Li, Yimin | |
| 700 | 1 | |a Zhou, Dan | |
| 700 | 1 | |a Hu, Qingqing | |
| 700 | 1 | |a Wu, Jinzhi | |
| 700 | 1 | |a Meng, Qingna | |
| 700 | 1 | |a Zhou, Jichun | |
| 700 | 1 | |a Xu, Danyi | |
| 700 | 1 | |a Yu, Jingyi | |
| 700 | 1 | |a Liang, Junyu | |
| 700 | 1 | |a Cai, Yangjun | |
| 700 | 1 | |a Zhang, Minmin | |
| 700 | 1 | |a He, Yanlin | |
| 700 | 1 | |a Sun, Zeyu | |
| 700 | 1 | |a Wang, Linbo | |
| 700 | 1 | |a Lin, Jin | |
| 700 | 1 | |a Ji, Feiyang | |
| 773 | 0 | |t bioRxiv |g (Jan 22, 2025) | |
| 786 | 0 | |d ProQuest |t Biological Science Database | |
| 856 | 4 | 1 | |3 Citation/Abstract |u https://www.proquest.com/docview/3158241600/abstract/embedded/J7RWLIQ9I3C9JK51?source=fedsrch |
| 856 | 4 | 0 | |3 Full text outside of ProQuest |u https://www.biorxiv.org/content/10.1101/2025.01.17.633562v1 |